Skip to main content
BioNumerik Pharmaceuticals, Inc. Home Page

Science & Technology

BioNumerik Pharmaceuticals, Inc. Feature

Mechanism-Based Drug Discovery

BioNumerik is a leader in “mechanism-based” drug discovery, which employs multi-disciplinary science, including chemistry, biology and quantum physics, integrated with high performance computational technologies, to identify, simulate and better understand the mechanisms by which drugs and their targets function. Our integrated approach aims to streamline drug development by selecting and optimizing promising drugs or compounds earlier in the discovery process.

Mechanism-based drug discovery has been pioneered by Dr. Frederick Hausheer, our founder and an expert in pharmaceutical discovery, clinical oncology drug development, pharmacology and in the development and application of pharmaceutical discovery software and supercomputing applications. We believe our approach represents a novel method of drug discovery relative to drug screening, automated screening and combinatorial chemistry, and rational mechanism-based drug designdiscovery.